Published 2012 Apr 18
If you are pregnant or breastfeeding, consult your healthcare provider before introducing new products
Tirzepatide is the active ingredent in both Mounjaro and Zepbound, while semaglutide is the active ingredient in brand name Wegovy and Ozempic medications
Tirzepatide showed a noninferior reduction in all-cause mortality (HR 0.88, 95% CI 0.68 to 1.16), myocardial infarction (HR 0.91, 95% CI 0.73 to 1.12) and stroke (HR 0.78, 95% CI 0.59 to 1.03) compared to dulaglutide, although CIs remained compatible with no difference
Excerpt from NBC news article: People who take popular drugs for weight loss, such as Ozempic or Wegovy, may be at an increased risk of severe stomach problems, research published Thursday in the Journal of the American Medical Association finds
doi: 10.1038/s42255-022-00730-6, 114